时隔14年AHA再发声明,血压测量的这些误区,可别再犯了

2019-03-06 小循 中国医学论坛报今日循环

高血压是诱发心脏病和卒中的重要危险因素,而准确测量血压对于诊断和管理高血压至关重要!作为患者,你会测血压吗?作为医务工作者,该如何更好地指导患者测量血压?

高血压是诱发心脏病和卒中的重要危险因素,而准确测量血压对于诊断管理高血压至关重要!作为患者,你会测血压吗?作为医务工作者,该如何更好地指导患者测量血压?

近日,美国心脏协会(AHA)发布新版血压测量的科学声明点击下载声明全文,新版声明最大的亮点是:力推使用经过验证的电子血压计。声明认为,使用电子压力传感器可以减少人为错误,且比水银血压计更环保。



新版声明是继2005版相关科学声明后的首次更新,梳理总结了目前已知的血压测量方法,并体现出了对2017版AHA/ACC(美国心脏病学会)联合发布的高血压预防、检测、评估和管理指南(以下简称2017版美国高血压指南)的支持。

1电子血压计准确、靠谱,更环保

袖带、听诊器、水银血压计可谓是诊室的“铁三角”组合,出镜率极高,长时间以来一直被认为是测量血压的“黄金组合”。但基于其环保问题,AHA新版声明不建议再使用水银血压计。

“电子血压计的准确性已通过验证,可准确测量血压,同时可以减少与听诊方法相关的人为误差。电子血压计通过一个按钮,即可获得多个测量值,智能计算平均值,可以更好地监测患者的血压水平”,新版科学声明写作小组主席保罗?蒙特纳(Paul Muntner)博士对电子血压计充满信心。

2血压到底高不高,动态血压监测来“说话”

声明还总结了目前关于动态血压监测的知识,强调了诊室外血压测量的重要性。

声明认为,白大衣高血压可能不会增加患者的血管病风险,使用降压药患者获益可能也不大,但隐蔽性高血压患者的血管病风险会显著增加。2017版美国高血压指南也建议,在临床实践中应进行动态血压监测,以筛查白大衣高血压和隐匿性高血压。

拓展阅读

隐蔽性高血压又称“逆白大衣高血压”或被掩盖的高血压,是指诊室内测量的血压正常,而动态血压监测发现平均血压水平升高。

3测量血压的正确方式

量左手还是量右手?

初次测量,应两边都量;重复测量时,要间隔1~2分钟。

躺着还是坐着,正确姿势应该是怎样的?

这些小知识,你知道吗?

仰卧时,手臂低于心脏,测量的收缩压要比坐着时量取的高3~10 mmHg,舒张压也要高1~5 mmHg,因此仰卧位测量时手臂下需要适当垫高。

坐位时,如果后背没有靠背,收缩压和舒张压会分别增加5~15 mmHg和6 mmHg。

上臂低于右心房水平,手臂下垂时,测出的血压会升高。

测量时跷二郎腿,会使收缩压升高5~8 mmHg,舒张压增加3~5 mmHg。

测血压时,过紧的衣物会压迫动脉,导致血压值不准确。

总结一下血压测量的正确打开方式:测量血压前30分钟勿运动、喝咖啡和吸烟,测量时应着宽松的衣物,身体要坐直,手臂自然放在桌面上,肘部与心脏保持在同一水平位置,双脚平放,不要说话。



原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1679369, encodeId=ee2d16e936952, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Sep 05 05:19:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363427, encodeId=67c636342e75, content=少翘二郎腿, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23512534224, createdName=1250a3a8m60暂无昵称, createdTime=Sat Mar 23 15:04:26 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268082, encodeId=cde9126808228, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308864, encodeId=034b13088644c, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362135, encodeId=19ef362135b5, content=不错,学习啦,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79b52561932, createdName=12565424m76暂无昵称, createdTime=Wed Mar 06 20:02:27 CST 2019, time=2019-03-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1679369, encodeId=ee2d16e936952, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Sep 05 05:19:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363427, encodeId=67c636342e75, content=少翘二郎腿, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23512534224, createdName=1250a3a8m60暂无昵称, createdTime=Sat Mar 23 15:04:26 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268082, encodeId=cde9126808228, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308864, encodeId=034b13088644c, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362135, encodeId=19ef362135b5, content=不错,学习啦,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79b52561932, createdName=12565424m76暂无昵称, createdTime=Wed Mar 06 20:02:27 CST 2019, time=2019-03-06, status=1, ipAttribution=)]
    2019-03-23 1250a3a8m60暂无昵称

    少翘二郎腿

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1679369, encodeId=ee2d16e936952, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Sep 05 05:19:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363427, encodeId=67c636342e75, content=少翘二郎腿, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23512534224, createdName=1250a3a8m60暂无昵称, createdTime=Sat Mar 23 15:04:26 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268082, encodeId=cde9126808228, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308864, encodeId=034b13088644c, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362135, encodeId=19ef362135b5, content=不错,学习啦,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79b52561932, createdName=12565424m76暂无昵称, createdTime=Wed Mar 06 20:02:27 CST 2019, time=2019-03-06, status=1, ipAttribution=)]
    2019-03-08 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1679369, encodeId=ee2d16e936952, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Sep 05 05:19:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363427, encodeId=67c636342e75, content=少翘二郎腿, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23512534224, createdName=1250a3a8m60暂无昵称, createdTime=Sat Mar 23 15:04:26 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268082, encodeId=cde9126808228, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308864, encodeId=034b13088644c, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362135, encodeId=19ef362135b5, content=不错,学习啦,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79b52561932, createdName=12565424m76暂无昵称, createdTime=Wed Mar 06 20:02:27 CST 2019, time=2019-03-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1679369, encodeId=ee2d16e936952, content=<a href='/topic/show?id=c0ee889564a' target=_blank style='color:#2F92EE;'>#血压测量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88956, encryptionId=c0ee889564a, topicName=血压测量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47e127763663, createdName=zxxiang, createdTime=Thu Sep 05 05:19:00 CST 2019, time=2019-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=363427, encodeId=67c636342e75, content=少翘二郎腿, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=23512534224, createdName=1250a3a8m60暂无昵称, createdTime=Sat Mar 23 15:04:26 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268082, encodeId=cde9126808228, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308864, encodeId=034b13088644c, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Mar 08 10:19:00 CST 2019, time=2019-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=362135, encodeId=19ef362135b5, content=不错,学习啦,感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79b52561932, createdName=12565424m76暂无昵称, createdTime=Wed Mar 06 20:02:27 CST 2019, time=2019-03-06, status=1, ipAttribution=)]
    2019-03-06 12565424m76暂无昵称

    不错,学习啦,感谢分享

    0

相关资讯

2017AHA/ASA关于"无症状脑血管病"的科学声明

2017年2月AHA联合ASA共同在Stroke上发布了无症状脑血管病的卒中预防科学声明,现将推荐意见摘录如下。

Circulation.:AHA 右心衰竭的评估和管理科学声明:应用利尿剂重要

近期,美国心脏协会(AHA)发布《右心衰竭的评估和管理科学声明》,对右心衰竭的病因、流行病学、病理生理学以及急慢性右心衰竭的管理进行了论述。

JAMA:美国糖尿病协会不同意ACC/AHA高血压指南:降压靶标为130/80有过度治疗之嫌

医学这门学科很年轻,因此有很多临床问题,不同学术组织思考的角度或对循证医学证据理解不同时,有时候就会“掐起架”来。

Circulation:AHA有关心血管病与卒中的统计数据之2018更新

近日,美国心脏协会(AHA)发布了有关心血管病和卒中的统计数据,其更新要点如下:

AHA公布2017年心血管病研究十大进展:脑卒中和高血压诊疗有重大变化

2月7日,美国心脏协会(AHA)官网公布了2017年心血管病研究十大进展,具体如下。

AHA 2018!没赶上前两日的报道?那今天报道一定不能再错过了!

2018AHA科学年会已经圆满落下帷幕!虽然大会时间压缩至3天,但是精彩内容未曾压缩,大会共集结了100多个国家超过16,000名专业人士前来参会,5,000多个报告,4,000多篇摘要,精彩程度可见一斑。让我们快速浏览一下本次大会上最新最热的血脂话题。